The report on the Global Exocrine Pancreatic Insufficiency Market gives an estimation of the development of the market based on historical studies and also provides forecasts on the basis of a comprehensive research. The report gives a complete market analysis for the forecasted period from 2020 to 2026. The market is divided into various segments with an in-depth outlook of the competitors and a listing of the profiled key players. The market size in terms of revenue (USD MN) is calculated and provided for the study period along with the dynamics of the market such as the drivers and the restraints.
Study period considered for research of this market:
TABLE OF CONTENTS
1 . PREFACE
1.1. Report Description
1.1.1. Objective
1.1.2. Target Audience
1.1.3. Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
1.3.1. Market Research Process
1.3.2. Market Research Methodology
2 . EXECUTIVE SUMMARY
2.1. Highlights of Exocrine Pancreatic Insufficiency Market
2.2. Global Exocrine Pancreatic Insufficiency Market Snapshot
3 . EXOCRINE PANCREATIC INSUFFICIENCY – INDUSTRY ANALYSIS
3.1. Introduction
3.2. Market Drivers of Exocrine Pancreatic Insufficiency Market
3.3. Market Restraints of Exocrine Pancreatic Insufficiency Market
3.4. Opportunities of Exocrine Pancreatic Insufficiency Market
3.5. Trends of Exocrine Pancreatic Insufficiency Market
3.6. Porter’s Five Force Analysis of Exocrine Pancreatic Insufficiency Market
3.7. Exocrine Pancreatic Insufficiency Market Attractiveness Analysis
3.7.1 Market Attractive Analysis by Therapeutics
3.7.2 Market Attractive Analysis by Diagnostic Tests
3.7.3 Market Attractive Analysis by Region
4 . VALUE CHAIN ANALYSIS
4.1. Exocrine Pancreatic Insufficiency Value Chain Analysis
4.2. Exocrine Pancreatic Insufficiency Raw Material Analysis
4.2.1. List of Raw Materials
4.2.2. Exocrine Pancreatic Insufficiency Raw Material Manufactures List
4.2.3. Price Trend of Exocrine Pancreatic Insufficiency Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
4.4.1. Direct Marketing
4.4.2. Indirect Marketing
4.4.3. Marketing Channel Development Trend
5 . GLOBAL EXOCRINE PANCREATIC INSUFFICIENCY MARKET ANALYSIS BY THERAPEUTICS
5.1 Overview by Therapeutics
5.2 Global Exocrine Pancreatic Insufficiency Market Analysis by Therapeutics
5.3 Market Analysis of Pancreatic Enzyme Replacement Therapy (PERT) Drugs by Regions
5.4 Market Analysis of Creon by Regions
5.5 Market Analysis of Zenpep by Regions
5.6 Market Analysis of Pancreaze by Regions
5.7 Market Analysis of Ultresa by Regions
5.8 Market Analysis of Viokace by Regions
5.9 Market Analysis of Pertzye by Regions
5.10. Market Analysis of Sollpura (Liprotamase) by Regions
6 . GLOBAL EXOCRINE PANCREATIC INSUFFICIENCY MARKET ANALYSIS BY DIAGNOSTIC TESTS
6.1 Overview by Diagnostic Tests
6.2 Global Exocrine Pancreatic Insufficiency Market Analysis by Diagnostic Tests
6.3 Market Analysis of Blood Tests by Regions
6.4 Market Analysis of Endoscopic Ultra-Sonography (EUS) by Regions
6.5 Market Analysis of Magnetic Resonance Imaging (MRI) by Regions
6.6 Market Analysis of CT Scanning by Regions
7 . GLOBAL EXOCRINE PANCREATIC INSUFFICIENCY MARKET ANALYSIS BY GEOGRAPHY
7.1. Regional Outlook
7.2. Introduction
7.3. North America
7.3.1. Overview
7.3.2. North America Exocrine Pancreatic Insufficiency Market Estimate by Market Segment
7.3.3. North America Exocrine Pancreatic Insufficiency Market Estimate by Country
7.3.4. United State
7.3.5. Rest of North America
7.4. Europe
7.4.1. Overview
7.4.2. Europe Exocrine Pancreatic Insufficiency Market Estimate by Market Segment
7.4.3. Europe Exocrine Pancreatic Insufficiency Market Estimate by Country
7.4.4. United Kingdom
7.4.5. France
7.4.6. Germany
7.4.7 Rest of Europe
7.5. Asia Pacific
7.5.1. Overview
7.5.2. Asia Pacific Exocrine Pancreatic Insufficiency Market Estimate by Market Segment
7.5.3. Asia Pacific Exocrine Pancreatic Insufficiency Market Estimate by Country
7.5.4. China
7.5.5. Japan
7.5.6. India
7.5.7. Rest of Asia Pacific
7.6. Latin America
7.6.1. Overview
7.6.2. Latin America Exocrine Pancreatic Insufficiency Market Estimate by Market Segment
7.6.3. Latin America Exocrine Pancreatic Insufficiency Market Estimate by Country
7.6.4. Brazil
7.6.5. Rest of Latin America
7.7. Middle East & Africa
7.7.1. Overview
7.7.2. Middle East & Africa Exocrine Pancreatic Insufficiency Market Estimate by Market Segment
7.7.3. Middle East & Africa Exocrine Pancreatic Insufficiency Market Estimate by Country
7.7.4. Middle East
7.7.5. Africa
8 . COMPETITIVE LANDSCAPE OF THE EXOCRINE PANCREATIC INSUFFICIENCY COMPANIES
8.1. Exocrine Pancreatic Insufficiency Market Competition
8.2. Partnership/Collaboration/Agreement
8.3. Merger And Acquisitions
8.4. New Product Launch
8.5. Other Developments
9 . COMPANY PROFILES OF EXOCRINE PANCREATIC INSUFFICIENCY INDUSTRY
9.1. Company Share Analysis
9.2. Market Concentration Rate
9.3. Abbvie Inc.
9.3.1. Company Overview
9.3.2. Financials
9.3.3. Products
9.3.4. Recent Developments
9.4. Allergan plc.
9.4.1. Company Overview
9.4.2. Financials
9.4.3. Products
9.4.4. Recent Developments
9.5. Nordmark Arzneimittel GmbH & Co. KG
9.5.1. Company Overview
9.5.2. Financials
9.5.3. Products
9.5.4. Recent Developments
9.6. Digestive Care, Inc.
9.6.1. Company Overview
9.6.2. Financials
9.6.3. Products
9.6.4. Recent Developments
9.7. Cilian AG
9.7.1. Company Overview
9.7.2. Financials
9.7.3. Products
9.7.4. Recent Developments
9.8. Anthera Pharmaceuticals Inc.
9.8.1. Company Overview
9.8.2. Financials
9.8.3. Products
9.8.4. Recent Developments
9.9. Janssen Pharmaceuticals Inc.
9.9.1. Company Overview
9.9.2. Financials
9.9.3. Products
9.9.4. Recent Developments
9.10. AzurRx BioPharma, Inc.
9.10.1. Company Overview
9.10.2. Financials
9.10.3. Products
9.10.4. Recent Developments
*Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies
LIST OF TABLES
The report on the Global Tigecycline Market gives an estimation of the development of the market based on historical studies and also provides forecasts read more..
The Global Risperidone Market Report is equipped with market data from 2015 to 2025. The report gives a market overview covering key drivers and risks read more..
The report on the Global Caffeine Market gives an estimation of the development of the market based on historical studies and also provides forecasts on read more..
The report on the Global Rabies Vaccine Market gives an estimation of the development of the market based on historical studies and also provides read more..
Radiopharmaceuticals Market Research Report offered by DecisionDatabases.com provides a detailed study on the industrial development of the market under read more..
The report on the Global Neurorehabilitation System Market gives an estimation of the development of the market based on historical studies and also read more..
The report on the Global Molecular Biology Kits And Reagents Market gives an estimation of the development of the market based on historical studies and read more..
The report on the Global High Acuity Care Information Systems Market gives an estimation of the development of the market based on historical studies and read more..
The global regenerative medicine market was estimated to be at ~$4.5 billion in 2013. A number of factors such as increasing bone related read more..
The report on the Global Skin Cancer Diagnostics Market gives an estimation of the development of the market based on historical studies and also read more..